Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Mounjaro

‘I lost four stone on Mounjaro – but piled weight back on when I couldn’t afford to keep taking it’

Darren Ratcliffe was paying £270 a month for weight-loss jab Mounjaro

The Independent UK

Mounjaro on the NHS: Expert advice on what you need to know

Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility criteria

The Independent UK

Mounjaro is available on the NHS. Here’s what to do if you’re not eligible

Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility criteria

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Mounjaro weight loss jabs now available from GPs – are you eligible?

Around 29% of the adult population in the UK is obese

The Independent UK

‘They think it’s cheating’: Why people won't praise Mounjaro and Ozempic weight loss

Imagine you finally get to your goal weight... and no one wants to talk about it. According to one study, this is the case with Mounjaro and Ozempic-induced weight loss

Evening Standard

How GLP-1 weight-loss drugs can mess with birth control and pregnancy, U.K. agency warns

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the effectiveness of oral contraceptives.

Fortune

“Traumatizing”: Mom Blasted After Toddler Pretends To Inject Her Weight-Loss Med On Camera

"What in the generational trauma is going on here?"

Bored Panda

Read news from The Economist, FT, and more,
with one subscription

“I Can’t Believe This Is Me”: Rosie O’Donnell Stuns With Dramatic Mounjaro Weight Loss

"i cant believe this is me now."

Bored Panda

Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’

Edward Fanelli, 57, shared his regrets about taking Ozempic after he was diagnosed with a rare eye condition.

The Independent UK

Who should avoid taking viral drug Mounjaro? Expert explains

Eli Lilly's recent launch of Mounjaro (tirzepatide) in India has sparked significant interest especially among those looking for weight loss and diabetes control.

The Times of India

Man who ‘begged’ NHS for weightloss jabs drops nine stone after going private

Mark Spurr dropped nine stone after starting weekly Mounjaro jabs eight months ago

The Independent UK

Whoopi Goldberg issues warning about fake social media ad of her endorsing weight loss treatment

‘The View’ host previously opened up about taking Mounjaro for weight loss

The Independent UK

How does weight loss drug Mounjaro work and why is it in such high demand?

The ‘King Kong of weight loss drugs’ will be available on the NHS but only patients with most need will get it

The Guardian - UK

Why some people don’t lose weight with Wegovy

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Ozempic, Wegovy or Mounjaro? The battle of the weight-loss injections

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them

Newcastle Herald

'Removing blame': New weight-loss drug for obesity and overweight people

First there was Ozempic, then Wegovy, now we have Mounjaro.

Top News

Whoopi Goldberg Reveals Using Weight Loss Drug Mounjaro After Health Scare

Whoopi Goldberg and Oprah Winfrey share their weight loss journeys and discuss societal stigma around obesity and weight loss medications.

Benzinga

Eli Lilly Presents New Analyses On Tirzepatide Injection For Type 2 Diabetes

Eli Lilly And Co (NYSE:LLY) presented new data from a mechanism of action study and new analyses of the global registration program for Mounjaro (tirzepatide) injection at the American Diabetes Association. At 28 weeks, participants taking Mounjaro (N=45) had significantly greater reductions in weight and fat mass compared to Novo Nordisk A/S's (NYSE:NVO) injectable Ozempic…

Get all your
news in one place.

100's of premium titles.
One news app.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

American Diabetes Association

12 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.